// App-Quantinova.ai

PB0670 : Bleed Outcomes in the Moderate and Mild Hemophilia A Population Without Prophylactic Treatment in CHESS II and CHESS PAEDs

Researchers

Presenter

  • K. Khair

Principal Investigators

  • F. Nissen

  • J. OHara

  • M. Aizenas

  • H. Zhang

  • K. Moreno

  • T. Burke

  • B. Nolan

Medical Centers

  • Haemnet, London, England, United Kingdom

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • HCD Economics, Daresbury, United Kingdom

  • HCD Economics and Faculty of Health and Social Care, University of Chester, Daresbury, England, United Kingdom

  • Roche Products Ltd., Welwyn Garden City, United Kingdom

  • Children's Health Ireland at Crumlin Dublin 2 Ireland

Locations

  • United Kingdom

  • Switzerland

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved